Unique ID issued by UMIN | UMIN000033878 |
---|---|
Receipt number | R000038188 |
Scientific Title | Treatment Utilizing Virtual Reality for Social Anxiety Disorder: A Feasibility Study |
Date of disclosure of the study information | 2018/08/24 |
Last modified on | 2023/05/28 07:55:31 |
Treatment Utilizing Virtual Reality for Social Anxiety Disorder: A Feasibility Study
Treatment Utilizing Virtual Reality for Social Anxiety Disorder: A Feasibility Study
Treatment Utilizing Virtual Reality for Social Anxiety Disorder: A Feasibility Study
Treatment Utilizing Virtual Reality for Social Anxiety Disorder: A Feasibility Study
Japan |
social anxiety disorder
Psychiatry |
Others
NO
We aim to investigate whether the interview in which facial expressions are changed by using the virtual reality technology can be effectively and safely performed for patients with social anxiety disorder
Safety,Efficacy
safety of the system
LSAS-J score decrease at 8 weeks
LSAS-J score decrease at the end of the intervention (16 weeks)
LSAS-J score decrease at 24 weeks
FNE score decrease at 8 weeks
FNE score decrease at the end of the intervention (16 weeks)
CSQ-8 score at 8 weeks
CSQ-8 score at the end of the intervention (16 weeks)
WAI-SF score at the end of first sessions
WAI-SF score at the end of eighth sessions
WAI-SF score at the end of sixteenth sessions
dropout rate
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Educational,Counseling,Training
Other |
40 minutes interview via WEB conference system (once a week over 16 weeks) in which the clinician's facial expression will be altered (smily or sadly) utilizing virtual reality technology
20 | years-old | <= |
70 | years-old | > |
Male and Female
Patients with SAD (DSM-5) who are not decisionally impaired
History of organic mental disorders
Coexistence of substance use disorders within 12 months
History of bipolar disorder or psychotic disorder
Received other structured psychotherapy within 12 months
Coexistence of serious or unstable physical illness
Patients with moderate to severe suicidality
Judged inappropriate for the purpose of this research for other reasons by the Research Director
5
1st name | Gen |
Middle name | |
Last name | Shiihashi |
Shonan Keiiku hospital
Doctors
252-0816
4360 Endo, Hujisawa city, Kanagawa, Japan
0466-48-0050
g-shiihashi@keiiku.gr.jp
1st name | Toshiro |
Middle name | |
Last name | Horigome |
Shonan Keiiku hospital
Doctors
252-0816
4360 Endo, Hujisawa city, Kanagawa, Japan
0466-48-0050
toshirou.ho@gmail.com
Shonan Keiiku hospital
Novartis Pharma K.K., Otsuka Pharmaceutical, Mochida Pharmaceutical, Shionogi, Takeda Pharmaceutical, etc
Other
Shonan Keiiku hospital
4360 Endo, Hujisawa city, Kanagawa, Japan
0466-48-0050
k-miyazaki@keiiku.gr.jp
NO
湘南慶育病院(神奈川県)
2018 | Year | 08 | Month | 24 | Day |
https://doi.org/10.3389/fpsyg.2023.1030050
Published
https://doi.org/10.3389/fpsyg.2023.1030050
4
Results suggest that this system is safe to use and may be effective in treating social anxiety disorder.
2023 | Year | 05 | Month | 28 | Day |
1 male, 3 females, mean age; 31.0 years
Recruitment of the participants was conducted through referrals from their primary psychiatrists.
none
WAI-SF, CSQ-8, LSAS-J, FNE
Completed
2018 | Year | 08 | Month | 06 | Day |
2018 | Year | 08 | Month | 06 | Day |
2018 | Year | 08 | Month | 25 | Day |
2022 | Year | 03 | Month | 31 | Day |
2018 | Year | 08 | Month | 23 | Day |
2023 | Year | 05 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038188
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |